Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Profit After Tax (2016 - 2025)

Avanos Medical's Profit After Tax history spans 11 years, with the latest figure at -$397.3 million for Q4 2024.

  • For Q4 2024, Profit After Tax fell 2646.79% year-over-year to -$397.3 million; the TTM value through Dec 2024 reached -$389.1 million, down 463.1%, while the annual FY2025 figure was -$72.9 million, 81.41% up from the prior year.
  • Profit After Tax for Q4 2024 was -$397.3 million at Avanos Medical, down from $5.9 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $38.5 million in Q2 2021 and bottomed at -$397.3 million in Q4 2024.
  • The 5-year median for Profit After Tax is $1.2 million (2024), against an average of -$24.0 million.
  • The largest annual shift saw Profit After Tax soared 1383.33% in 2021 before it plummeted 2646.79% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$49.0 million in 2020, then surged by 47.55% to -$25.7 million in 2021, then surged by 165.76% to $16.9 million in 2022, then decreased by 7.69% to $15.6 million in 2023, then tumbled by 2646.79% to -$397.3 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Profit After Tax are -$397.3 million (Q4 2024), $5.9 million (Q3 2024), and $1.8 million (Q2 2024).